ImaginAb and Quibim partner to revolutionize immune status diagnosis and immunotherapy prediction

/PRNewswire/ -- ImaginAb Inc., a global biotechnology company developing 89Zr crefmirlimab berdoxam (CD8 ImmunoPET™) imaging agent and radiopharmaceutical...

Related Keywords

Spain ,Valencia ,Carabobo ,Venezuela ,Madrid ,Ian Wilson ,Prnewswire Imaginab Inc ,Imaginab Inc ,Chief Executive Officer ,New York ,United States ,United Kingdom ,Imaginab ,Nc ,